DUBLIN--(BUSINESS WIRE)--The "Women's Health Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.
The report predicts the global women's health market to grow with a CAGR of 5.72% over the forecast period of 2018-2024.
The report on women's health market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global women's health market over the period of 2016 to 2024. Moreover, the report is collective presentation of primary and secondary research findings.
Porter's Five Forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global women's health market over the period of 2016 to 2024. Further, the author's Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.
The global women's health market is segmented on the basis of treatment type, diseases indication and distribution channel.
Global Women's Health Market by Treatment Type
Global Women's Health Market by Diseases Indication
- Uterine Fibroid
- Post-Menopausal Syndrome
- Urinary Tract Infection
Global Women's Health Market by Distribution Channel
- Online Pharmacy
- Hospital Pharmacy
- Retail Pharmacy
- Novartis AG
- Merck & Co., Inc.
- Amgen Inc
- Eli Lilly and Company
- Lupin Pharmaceuticals, Inc.
- Novo Nordisk A/S
- Pfizer, Inc.
For more information about this report visit https://www.researchandmarkets.com/research/v7gvrj/global_womens?w=4